Home Your basket
• Personal experience about...
   Price 10.50 €
• Vestibular neuritis: aeti...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• Parathyroid cervical haem...
   Price 8.50 €
• Papillary thyroid microca...
   Price 8.50 €
• Arteriovenous haemangioma...
   Price 8.50 €
• Vocal rehabilitation with...
   Price 10.50 €
• "Bamboo nodes" : a clinic...
   Price 8.50 €
• Psychosocial quality of l...
   Price 10.50 €
• Aspects of ageing on prof...
   Price 12.00 €
• Histology of the larynx....
   Price 8.50 €
• Voice prostheses: long-te...
   Price 10.50 €
• Adaptation and validation...
   Price 10.50 €
• Training strategies of th...
   Price 8.50 €
• Use of inomeric cement: P...
   Price 10.50 €
• Facial threads for face l...
   Price 10.50 €
• Cervico facial lymphangio...
   Price 10.50 €
• Fronto-ethmoidal mucocele...
   Price 8.50 €
• Bronchoscopic findings in...
   Price 10.50 €
• Hearing aids rehabilitati...
   Price 12.50 €
• Cervical cystic lymphangi...
   Price 5.50 €
• Dysphonia and cervical hy...
   Price 5.50 €
• Validity of cervical ausc...
   Price 12.00 €
• Medicamentous toxic heari...
   Price 5.50 €
• Air rifle pellet injury t...
   Price 5.50 €
• Nasal septal abscess: A c...
   Price 5.50 €
• A case of laryngeal sialo...
   Price 10.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Reconstruction of the ant...
   Price 8.50 €
• Aneurysmal bone cyst of t...
   Price 5.50 €
• One-stage surgery of midd...
   Price 8.50 €
• Interventional phoniatry...
   Price 14.00 €
• How I do it: Salivary duc...
   Price 8.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Interest of hypnotherapy ...
   Price 10.50 €
• Frontal sinus osteoma com...
   Price 5.50 €
• Focus on the BPPV: Semont...
   Price 12.50 €
• Relevance of Choukroun’s ...
   Price 8.50 €
• Study on the modeling of ...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €

Total Order 357.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2000 o

RHINOLOGY

Acceptability of topical administration of a combination of corticoid (beclomethasone) and antihistamine (azelastine) in the treatment of allergic rhinitis.


Authors : D. Portmann, M. Le Gal, V. Jessent, J.-L. Verrière (Bordeaux, Lyon)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,4:273-280.

Article published in french
Downloadable PDF document french



Summary : A prospective multicentre study involving 219 patients with seasonal or aperiodic rhinitis was performed to assess the acceptability of a local treatment combining antihistamine (azelastine) and corticoid (beclomethasone) drugs. The drugs were administered either together (morning and evening, with a 5-minute interval) or separately (azelastine in the morning and evening, and beclomethasone later during the morning and in the afternoon) for 15 days. Treatment acceptability was measured by a nine-fold questionnaire (7-point scale, mean score per question). Patient participation, protocol and therapy compliance, and treatment efficacy and tolerance were also studied. The acceptability of the association was satisfactory (mean score for general facility of treatment: 4.7 / 6) and did not differ between administration schedules. Patients found treatment easy, and were not bothered by the bulk of the bottles or the risk of mixing them up. This acceptability was confirmed by the low percentage (4 %) of patients refusing to be included in the study (refusing any treatment by nasal spray). The general acceptability was confirmed by the results for therapy compliance, general efficacy and tolerance: 94.9 % of the patients took more than 75 % of the administrations prescribed, 77.6 % of the patients and 85.2 % of the practitioners judged treatment efficacy as good or excellent, and 84.6 % of the patients and 91.4 % of the practitioners judged tolerance as good or excellent. Moreover, most of the adverse events consisted of minor signs of local intolerance, and were identical to those observed when the two treatments were administered alone.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE